What is Bitmis Corp?
engages in the research and development, production, marketing, and sale of natural ß-carotene health food products in the People's Republic of China.
BIMT · Verdict
Limited reward · elevated risk
BIMT has limited near-term tailwinds — profitability and growth weigh on the model output.
Based on 88% data coverage
BIMT · Verdict
-509% net margin · 0% ROE
Rev -44.1% CAGR · earnings -18.7%
-551% free-cash-flow margin
Below average
Below average
Model-based scoring. For information only — not financial advice.
engages in the research and development, production, marketing, and sale of natural ß-carotene health food products in the People's Republic of China. It offers consultancy and information technology support; and research, promotion, and support services, as well as various forms of products, such as liquid, powder, and pasta. The company is listed on the PINK in USA, operating in the Technology sector, with a market capitalisation of 15.95M.
The scoring profile indicates weak reward characteristics across most factors, including momentum and size. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.